Caricamento...
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
The discovery of the immune checkpoint mechanism has contributed greatly to recent advances in cancer treatment. The anticytotoxic T lymphocyte-associated protein 4 antibody ipilimumab was first approved as a therapeutic drug for malignant melanoma in the USA in 2011; since then, antiprogrammed cell...
Salvato in:
| Pubblicato in: | ESMO Open |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6307608/ https://ncbi.nlm.nih.gov/pubmed/30622744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000455 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|